In Re Zantac Ranitidine Litigation

Key Facts

Issues

• The Superior Court held that Delaware law does not recognize a threshold dose requirement as part of the general causation analysis. Appellants argued this was error, but the court declined to address this issue on appeal since it reversed the decision on other grounds, noting there is no consensus in Delaware law as to threshold dose requirements.
• The appeal concerns whether general causation expert opinions can be based on studies of the toxic agent (NDMA) without establishing a reliable scientific link to the product (ranitidine). The court reversed the Superior Court, holding that experts must demonstrate that exposure levels in studies are comparable to exposure from the product itself, following Delaware precedent from In re Asbestos Litigation and General Motors Corp. v. Grenier.
• The case addresses whether the Superior Court erred in adopting a 'liberal thrust' standard favoring expert testimony admissibility under Delaware Rule of Evidence 702, contrary to the preponderance-of-the-evidence standard required by Daubert and federal law. The court held that the Superior Court failed to properly act as a gatekeeper by dismissing methodological challenges to expert opinions as questions of weight rather than admissibility, and that Delaware's standard is consistent with the federal standard.

Holdings

Remedies

Legal Principles

• The party seeking to introduce expert testimony bears the burden of establishing its admissibility by a preponderance of the evidence. The trial court must determine whether the proponent has met this burden before allowing the expert to testify. Dismissing methodological challenges as going to weight rather than admissibility improperly abdicates the court's gatekeeping role under DRE 702.
• Under Delaware Rule of Evidence 702 (DRE 702), the proponent of expert testimony bears the burden of establishing that the opinion is based on sufficient facts or data and on dependable principles and methods that are reliably applied to the facts of the case by a preponderance of the evidence. The trial court must act as gatekeeper and determine whether expert testimony is both reliable and relevant before admitting it. Challenges to the sufficiency or reliability of expert methodology are questions of admissibility, not weight, and cannot be dismissed as matters for the jury.
• In toxic tort cases, general causation addresses whether a substance is capable of causing a particular injury in the general population. An expert's opinion must reliably bridge the gap between the disease-causing agent and the product at issue. Experts cannot rely on studies of the toxic agent alone without scientifically linking the exposure in those studies to the exposure caused by the product. Plaintiffs must show that the product (not just the toxic agent) may cause the alleged cancers.
• The proponent of expert opinion testimony must prove its admissibility by a preponderance of the evidence. The trial court must resolve preliminary questions of admissibility and cannot apply a presumption favoring admission. The Federal Advisory Committee on Evidence Rules clarified that treating reliability requirements as questions of weight rather than admissibility is an incorrect application of Rule 702 and Rule 104(a).

Precedent Name

• In re Asbestos Litigation
• General Motors Corp. v. Grenier
• Kumho Tire Co. v. Carmichael
• Daubert v. Merrell Dow Pharmaceuticals, Inc.
• In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.
• Bowen v. E.I. DuPont de Nemours & Co.

Cited Statute

• DRE 104(a)
• Federal Rule of Evidence 702
• FRE 104(a)
• Delaware Uniform Rule of Evidence 702

Judge Name

• Justice Valihura
• Justice Traynor
• Justice Legrow
• Justice Griffiths
• Chief Justice Seitz

Passage Text

• We reverse. First, the Superior Court erred in adopting a standard that favored or presumed the admissibility of expert testimony. Under our rules and existing precedent, the proponent of an expert opinion bears the burden of establishing that the opinion is based on sufficient facts or data and on dependable principles and methods that are reliably applied to the facts of the case. Unless these sufficiency and reliability elements are established by a preponderance of the evidence, the opinion is not admissible. Delaware's evidentiary rules governing expert testimony are consistent with federal law. A trial judge must act as the gatekeeper of expert testimony and should not dismiss challenges to the sufficiency or reliability of an expert opinion by viewing the disputes as questions for the jury to weigh.
• The experts' reliance on, and the Superior Court's acceptance of, studies regarding NDMA, without connecting the NDMA exposure in those studies to the exposure caused by ranitidine—the product at issue—was inconsistent with DRE 702 and Delaware law. A general causation expert's opinion must focus on the product at issue and must show that exposures examined in non-product studies on which the expert relied are reliably linked to the exposures caused by the product at issue.
• In sum, we conclude that the trial court misinterpreted DRE 702 and the Plaintiffs' burden in three ways. First, the trial court stated that DRE 702 should be applied with a 'liberal thrust' favoring admission, contrary to the preponderance-of-the-evidence standard and Daubert. Second, the court misconstrued Delaware's admissibility standard as being different from, and impliedly more permissive than, the analogous federal standard. Third, the court dismissed any argument regarding the experts' application of methodology as going to weight rather than admissibility, relinquishing the court's role as a gatekeeper. These collective errors resulted in the court finding that Plaintiffs' experts' opinions were admissible even though their sufficiency and reliability was not established by a preponderance of the evidence.